Wendy, the mother of a 25-year-old woman with terminal cancer who is pushing to be prescribed the drug Pembrolizumab, spoke to Philip Boucher-Hayes on Liveline about the shock of her daughter's diagnosis at such a young age and their fight to be treated with a costly immunotherapy drug not yet licensed to treat cervical cancer.
Her daughter, Alice, has been given less than a year to live.
"Time is of the essence…They start talking about side-effects of a new drug, you know? I’ve already said I’ll sign a form to say that we won’t hold anyone responsible for side effects of this drug. Because we have no choices left to us."
Listen back to the whole conversation on Liveline here.